NIH Funding · FY2024
Total Funding
$3.3M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#2,189
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $3.3M across 1 grant · National rank #2189.
Top grants by award amount
Roberto Ciccocioppo's NIH grant portfolio, ranked by award amount.
- 5UG3DA059285-02UG3Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD)$3.3Maward amount
Affiliation
Institutions that have administered grants for Roberto Ciccocioppo.
Affiliated with Park Therapeutics, Inc. (NJ).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardPark Therapeutics, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2189
- 2024Entered Top 25% NationallyRanked #2189
Related investigators
Other NIH-funded PIs frequently associated with Roberto Ciccocioppo.
Explore further
Find collaborators for Roberto Ciccocioppo
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Park Therapeutics, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →